natalizumabinterferon β-1asecondary progressive multiple sclerosis
…peutic lag and differences between ASCEND and SPECTRIMS trials, natalizumab, compared with interferon β-1a, reduces disability progression …
2articles mentioning drugs
12drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: interferon β-1a ×
interferon β-1a
This drug is selected. Its supporting articles are shown below.
Articles mentioning interferon β-1a
2 articles · page 1 of 1natalizumabinterferon β-1asecondary progressive multiple sclerosisASCEND
…etween placebo groups (HR 0.36, 95% CI 0.20 to 0.63, p=0.0004), natalizumab remained associated with a lower hazard of disability progressi…